# Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients

> **NCT06726889** · — · RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 104 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BEHAVIORAL:** Standard care
- **BEHAVIORAL:** Decision Support System (DSS)
- **BEHAVIORAL:** Reminders
- **BEHAVIORAL:** Feedback

## Key facts

- **NCT ID:** NCT06726889
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-25
- **Primary completion:** 2025-04
- **Final completion:** 2025-04
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2024-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06726889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06726889, "Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06726889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*